Literature DB >> 7674795

[Pathologic fractures: diagnostic and therapeutic considerations and results of treatment].

F Maurer1, T Ambacher, R Volkmann, S Weller.   

Abstract

Compared with bone fractures caused by trauma, pathologic fractures due to diseased bone are rare events. A pathologic fracture is one that occurs without adequate trauma and is caused by a benign or malignant bone lesion. Diagnosis of the basic disease is important for the subsequent therapy. In cases of benign bone lesions the aim of treatment is total osseus healing with complete restoration of function. In malignant pathologic fractures surgery is an essential part of the overall oncologic treatment design. In most cases it is combined with adjuvant therapy. Various surgical procedures are available for fractures at different sites and depending on whether the operation is performed with curative or palliative intent. In cases of progressive neoplastic disease stabilization is necessary to attenuate pain and to maintain mobility. Between 1983 and 1993 we treated 131 patients with 143 pathologic fractures. Conservative therapy was possible in 10 cases, while 133 fractures had to be treated surgically. Most fractures were caused by skeletal metastasis (61), solitary bone cysts (19), osteoporosis (17) and plasmocytoma (16). The most frequent localizations of pathologic fractures were humerus and femur. The favoured methods of surgical stabilization were endoprosthesis and reinforced osteosynthesis. Most fractures appeared in adolescent patients up to the age of 19 and in adults between the 5th and the 7th decade, and 57.3% of the fractures were caused by a primary or secondary malignant tumour lesion. Surgical treatment was performed in all but 1 case of malignant pathologic fractures. Of 74 patients, with malignant bone lesions 6 (8.1%), are still alive. For 68 patients who died after stabilization, the average survival time was 11.6 months; individual survival time depended on the kind of the tumour present. In 55 patients with fractures in the area of benign bone lesions complete healing was achieved, in 9 cases with conservative therapy. The rate of recurrence for solitary bone cysts treated by curettage or segment resection was 23.5%. Compared with the recurrence rates published by other authors this is a very good result.

Entities:  

Mesh:

Year:  1995        PMID: 7674795     DOI: 10.1007/bf00207909

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  27 in total

1.  [Managing pathologic femoral fractures in malignant bone tumors and skeletal metastases].

Authors:  W Kurock; T Sennerich; W D von Issendorff
Journal:  Langenbecks Arch Chir       Date:  1989

Review 2.  [Benign and semi-malignant bone tumor and tumorous lesions as a cause of pathologic fracture].

Authors:  E H Kuner
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1989

Review 3.  [Osteoporosis as a cause of pathologic fracture].

Authors:  H W Minne
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1989

4.  [Pathological fracture of the proximal femur and its therapy].

Authors:  H Cotta; K Rohe
Journal:  Aktuelle Traumatol       Date:  1984-08

5.  [Exceptional indications for interlocking nailing: pathologic fractures in the metastatic foci].

Authors:  G Berentey
Journal:  Hefte Unfallheilkd       Date:  1983

6.  [Selection of procedure in the management of recurrent juvenile and aneurismatic bone cysts].

Authors:  E H Kuner; R Kirchner; M Häring
Journal:  Chirurg       Date:  1977-12       Impact factor: 0.955

7.  [Fractures in benign bone cysts].

Authors:  H Röhner; U Pfister; P J Meeder; S Weller; J Uhrig
Journal:  Aktuelle Traumatol       Date:  1984-04

8.  [Pathologic fractures of the hip joint].

Authors:  A Lies; J Rehn
Journal:  Aktuelle Traumatol       Date:  1984-04

9.  [Pathological fractures in childhood and adolescence in benign and semi-malignant bone tumors and tumorous and inflammatory bone changes].

Authors:  Y M Goudarzi; F Sautmann
Journal:  Aktuelle Traumatol       Date:  1987-04

10.  [Surgical tactics in malignant bone tumors].

Authors:  M Salzer; K Knahr
Journal:  Langenbecks Arch Chir       Date:  1987
View more
  4 in total

1.  Malignant bone tumors in Kuwait: a 10-year clinicopathological study.

Authors:  K C Katchy; F Ziad; S Alexander; H Gad; M Abdel Mota'al
Journal:  Int Orthop       Date:  2005-09-29       Impact factor: 3.075

Review 2.  [Cystic bone changes. Etiology, diagnosis, therapeutic principles and personal results of treatment].

Authors:  F Maurer; T Ambacher; S Weller
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Acute Lymphoblastic Leukemia presenting as a Pathologic Fibular Fracture.

Authors:  Aditi Iyer; Rohan Mangal; Thor Stead; Andrew Barbera
Journal:  Orthop Rev (Pavia)       Date:  2022-08-25

4.  Thermoresponsive Catechol Based-Polyelectrolyte Complex Coatings for Controlled Release of Bortezomib.

Authors:  Berthold Reis; David Vehlow; Tarik Rust; Dirk Kuckling; Martin Müller
Journal:  Int J Mol Sci       Date:  2019-12-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.